Blanca Hernando

Suggest Changes
Learn More
2529 Background: PET offers a non invasive tool to assess cancer biology, staging tumors and potentially monitoring treatment response, anti-angiogenic therapy included. The aim of this study was to(More)
PURPOSE Adding taxanes to anthracycline-based adjuvant therapy improves survival outcomes of patients with node-positive breast cancer (BC). Currently, however, most patients with BC are node(More)
We report the study of structural and magnetic properties of Ni<sub>50</sub>Mn<sub>50 - x</sub>Sn<sub>x</sub>(x = 11 and 12.5) and Ni<sub>49</sub>Mn<sub>51 - x</sub>Sn<sub>x</sub>(x = 13) Heusler(More)
TPS153 Background: Despite several investigations, currently there are no proven biomarkers of bevacizumab efficacy. These studies are in advanced cancers and types of biomarkers and/or time points(More)